ATEC Alphatec Holdings Inc

CARLSBAD, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a medical device company that provides customized products and a broad suite of spine fusion solutions, announced today that it has named noted neurosurgeon Bret B. Abshire, M.D., MS to its Scientific Advisory Board. The appointment reinforces Alphatec's commitment to becoming a leader in spinal technology through collaboration with leading surgeon partners and is the sixth appointment the Company has made to its Scientific Advisory Board. Dr. Abshire's area of special expertise includes disorders of the cervical, thoracic, and lumbar spine, and he is skilled in complex re-operative spine surgeries with spinal instrumentation. He is a member of the neurosurgical faculty at the University of California, San Diego serving as Assistant Clinical Professor of Surgery; Vice Chair of the Surgery Department at the Southwest Healthcare System in Southern California; has participated in several clinical studies involving the treatment of spinal disorders and has had a number of papers published in scientific journals. Dr. Abshire is a member of the American Association of Neurological Surgeons and he maintains a private, general neurological practice performing surgery for brain tumors and cerebrovascular disease. Dr. Abshire joins other distinguished surgeons and thought leaders on Alphatec's Scientific Advisory Board including Stephen H. Hochschuler, M.D.; Frank Eismont, M.D.; Steven Garfin, M.D.; Frank Phillips, M.D.; and James J. Yue, M.D. Ronald Hiscock, President and Chief Executive Officer, said, "We are honored that Dr. Abshire, an esteemed member of the neurosurgical community, has agreed to serve on our Scientific Advisory Board. Dr. Abshire's experience and reputation as an innovative thought leader in neuro/spinal surgery will be a real asset in helping shape the development of our products. His involvement in our product development process underscores Alphatec's commitment to surgeon-driven product innovation." Dr. Abshire received a Bachelors of Science degree in animal physiology from the University of California, San Diego, and then went to the University of Health Sciences at The Chicago Medical School where he received both a Masters of Science degree in applied physiology and a medical degree. He completed his surgical internship and neurosurgery residency at The Cleveland Clinic Foundation and had a spine fellowship at the University of South Florida / Tampa General Hospital. About Alphatec Alphatec is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Alphatec's principal product offerings are primarily focused on the U.S. spine fusion market, which is estimated to approach $3 billion in 2007, through its wholly-owned subsidiary, Alphatec Spine, Inc., and include a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients' needs. In addition to Alphatec's U.S. presence, it also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc. Our mission is to be a value based leader in the spinal device market by providing unmatched service to and taking scientific direction from our surgeon customers. We do so through our unique in-house manufacturing facility in Carlsbad, California that allows us to respond quickly to surgeon needs and to customize innovative products needed for spine fusion surgery. Forward Looking Statements This press release may contain forward-looking statements that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: Alphatec's ability to maintain its level of previously reported sales growth, Alphatec's ability to develop and expand its spine fusion business in the United States and Japan, Alphatec's ability to expand and maintain a successful sales and marketing organization, continuation of favorable third party payor reimbursement for procedures performed using our products, unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec's ability to achieve profitability, uncertainty of additional funding, uncertainty of success in developing any new products, failure to successfully introduce and develop new products, including products related to license agreements, failure to obtain FDA clearance or approval for particular devices, Alphatec's ability to compete with other competing products and with emerging new technologies within and outside of spinal fusion, product liability exposure, patent infringement claims and claims related to our intellectual property. Please refer to the risks detailed in Alphatec's Form S-1 on file with the SEC, as well as the risks detailed from time to time in Alphatec's SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. Investor Relations: Alphatec Holdings, Inc.: Matt Clawson Stephen T. D. Dixon Allen & Caron, Inc. CFO and Vice President (949) 474-4300 (760)-431-9286 DATASOURCE: Alphatec Holdings, Inc. CONTACT: Matt Clawson of Allen & Caron, Inc., +1-949-474-4300, , for Alphatec Holdings, Inc.; or Stephen T.D. Dixon, CFO and Vice President of Alphatec Holdings, Inc., +1-760-431-9286 Web site: http://www.alphatecspine.com/

Copyright